EDUCATE AND EMPOWER

WHO’s End TB Strategy envisions a world free of TB and to achieve this, it calls for a patient centered approach and policies geared towards achieving this.
Talking of policies, when it comes to health, provision of facilities, concessions and care alone are not enough. Key to health is behavioral change and literacy plays a vital role in achieving this. Too often, policies are focused on eliminating poverty, physical barriers etc. but very little emphasis is given to literacy.
Literacy endows an individual with the capacity to analyze, think about outcomes of actions and gives the confidence of self-efficacy. Interestingly a research on India published in the journal Social Science and Medicine shows that “literacy – a non-income good – has a greater impact on public health in India.” The researchers, based at Cambridge’s Department of Sociology, say that even a poor district can achieve better public health with literacy for literacy endows an individual with capacity to comprehend medicine labelling, access healthcare, and engage with public health programmes.
If the public is better engaged in health programs, the efficacy of such programs will be better and DOTS is no exception.
The world would not have witnessed such a mess with antibiotic abuse if the public were more actively engaged in their health management. While it is unrealistic to expect the public to know the nuances of medicines, a public that is more actively engaged in understanding the pros and cons of the treatment that they are undergoing, a public that thinks of the future and a public that demands efficient healthcare policies could have made the world a better place.
All this is possible only with education. This reminds me of a shloka that my daughter learnt in her Sanskrit class.
annadAnaM paraM dAnaM vidyAdAnaM ataH param |
annena kShaNikA tRuptiH yAvajjIvaM cha vidyayA ||

अन्नदानं परं दानं विद्यादानं अतः परम् ।
अन्नेन क्षणिका तृप्तिः यावज्जीवं च विद्यया ॥

Meaning, feeding the hungry is a good charity but greater is the charity of imparting knowledge. For feeding only temporarily relieves hunger. If we endow a person with knowledge it impacts that person lifelong.
OSDD is committed towards combating neglected diseases and let’s not forget that illiteracy is a bigger and neglected disease that inflicts humanity. So let’s take a vital step this WORLD TB Day 24 March 2015 to fight it.
So on this world TB day, as the world is engaged in various programs to combat TB, let’s resolve to educate our masses and empower them to fight TB!

WOMAN EMPOWER THYSELF!

Its women’s day and the whole world focuses on issues impacting women. Currently the global focus is on women’s empowerment and a crucial component to this is women’s health. Too often women are mired in familial responsibilities that their health becomes a low priority.

In the above context, the burden of TB on women cannot be understated. To quote the WHO, “In 2013, an estimated 3.3 million women fell ill with TB, of which the African and South East Asia regions accounted for nearly 70% of cases. TB is among the top killers of women of reproductive age. 510,000 women died from TB in 2013”. After all TB does not affect the women alone, she can be an easy transmitter to her child. So it is time that women are sensitized to this facet of their health and they need to be taught that they can take charge of this issue.

To do this as a women you need to believe that combating TB is a very important issue to you and that you can do it.
What can you do?
 Believe in yourself that you can make a difference.
 Be committed to the cause as a priority and necessity.
 Demand Women-friendly services in TB screening, prevention, treatment, integration of TB screening in well women health check-ups, maternal care etc.
 Talk! Talk!-Talk about it at your home, community, social media, visual media and create awareness.
 Integrate – TB screening, control, treatment programs in your women’s social group activities.
 Aid – Help in data collection, management and R&D activated by providing accurate information. This could go a long way in helping the professionals.

REMEMBER YOU ARE THE CRUCIAL LINK and YOU COUD MAKE A DIFFERENCE.

There are innumerable issues affecting women and most of them are caused by factors beyond their control. But health is an issue where a woman can emphasize her right and must stand up against discrimination. After all affordable healthcare is for all!

So WOMAN EMPOWER THYSELF TO COMBAT TB and power your way to success!

FILLING THE GAP

Stop TB partnership’s World TB day manifesto for 2015 predicts that there is an annual gap of US$ 1.39 billion in funding research and development for TB. As a research community, it is our prerogative to impress upon the funding sources to invest in TB R&D. But how can we make it attractive to invest in TB R&D?
We can make a strong case for the need to bring out more effective tools to combat TB, we can highlight the economic burden to the society and the domino effect of TB infecting and pulling down the social network, all this has been around for years and we yet we have always been left wanting for more funds. So how effectively can we attract more funds into TB R&D?
Nothing succeeds like success and if we can show effective roadmaps, successful milestones and above all innovative path breaking strategies it is sure to be attractive. With 8000 participants across 130 countries OSDD stands an outstanding crusader for the cause of neglected diseases. With big pharma companies shying away from investing, our chances of attracting funds rests on sensitizing the stakeholders in TB. We need to be more efficient to be effective. Tomorrow’s success starts with today and we need to leverage on our crowd sourcing strength. Pulling together on this diverse force is our strength but it could also prove to be our bane. The hind side is that such a diverse crowd could mean lack of focus and at times feeling unconnected. We need come up with more strategies to feel connected to feel the pulse of every participant and show the world that WE CAN AND WE CARE!
In the above context, I propose an initiative “TOGETHER WE CARE”. A virtual hub where all the participants get their space. A day for a participant. On that particular day, that participant gets to share his/her work, goals, dreams, doubts and ambitions with the community. This way with focus a day on a participant, we get to know every one better, connect better and more and better ideas may emerge. Currently our interactions are limited to meetings, discussions, posts etc. where the individual may at times get lost. While the institution is greater than the individual, it is the individual that makes the institution.

Thus we can make an effective community, show the world and our stakeholders that we are progressive. Our only chance to attract funding for R&D is to impact the stakeholders and what better way can there be than showing them that we are in this together and that we are focused. Thus we can fill the gap.
Any takers?

MEDIA AND TB

The impact of media on the psyche of the public can never be understated. Reach TB network works towards fostering a solution for the TB crisis and their media for TB wing focuses on media coverage of TB issues and gives away annual fellowship for TB coverage in local and national media. Ms Anupama Srinivasan Technical Consultant, REACH Media Projects talks to us about her thoughts on health communication and TB .

http://www.reachtbnetwork.org
http://www.media4tb.org
1. How is the role of health communication perceived in our country?

When we talk about health communication, I think it is very important to distinguish between communication on health that non-profit organisations, civil society and advocacy groups do, and health journalism. In the NGO space, communication isn’t always a priority, unfortunately. Given our (often) limited resources, the focus is inevitably on implementation of projects, and many of us do not invest time in documenting our work or disseminating it. There is also a paucity of trained communications professionals who are interested in working on health issues.

However, there are exceptions and the HIV movement in India is one that immediately comes to mind. HIV made room for itself in the public mindspace in an unprecedented way – primarily because of the efforts of non-profit organisations working on HIV. We have all read inspiring stories of and by people living with HIV and this has made a huge difference in dispelling stigma, to some extent, at least in some parts of the country.

When it comes to journalism, again, health is often not a priority although this is slowly changing. Reporting on politics, sports and film remain the first choices of young journalists. However, there is little doubt that the public continues to both trust and rely on the quality of the information they receive through media reporting on health. This makes it all the more important for us to try our best to improve both the quality and regularity of media reporting on health.

2. Can you share your experiences (success as well as stumbling blocks) with regard to the above?

I began my working life as a journalist/documentary filmmaker and worked on many different health issues including HIV, schizophrenia and suicide prevention, among others. What I realised very soon is that ‘health messaging’ is rather tricky and not as straightforward as it appears. There are many questions that we need to keep asking ourselves – what do we want to convey? How do we want to convey it? How often? Using which mediums and formats? This is equally important for non-profit organisations – to have clarity on the messages they disseminate, how they phrase these and what impact they hope this communication will have.

For the last four years, I’ve been working closely with journalists across the country as part of our efforts to improve the quality of media reporting on TB. As a media consumer, someone who reads the newspapers and watches the news, it would be very easy to become cynical about the state of journalism. And yes, sometimes, I am cynical. But in the last few years, I have been privileged to meet and work with so many wonderful journalists who have dedicated their careers to reporting on health and other development issues, despite the many challenges they face. Personally, for me, it has been so gratifying to see the kind of effort that a journalist is willing to invest in researching and writing a single 300-word story on multi-drug resistant tuberculosis. The dedication and commitment I have witnessed has only urged me, and my colleagues, to continue our efforts to offer these journalists the support they need.

 
3. Can you briefly let us know the work of media4tb?

Media4tb is an initiative of REACH, a non-profit organisation based in Chennai, with support from the Lilly MDR-TB Partnership. Since 2010, we have been working closely with journalists across the country. Our objective is simple – we want to improve the quality and frequency of reporting on TB in India. The four main aspects of our work include annual fellowships for journalists, particularly those reporting in languages other than English; annual media awards to recognise the best reporting on TB; resources on different aspects of TB for journalists and several research activities. We also respond to any questions that journalists may have about TB, especially when there are new developments in diagnostics or treatment.

4. How does your organization ensure the involvement of all the stakeholders in TB prevention and control?

Since REACH began in 1998, we have striven to build partnerships with several different stakeholders – private practitioners, the public health sector, pharmacists, the corporate sector and of course, the media. For example, we work closely with several private practitioners who refer their TB patients to our PPM centres (public-private mix). We then support the patient through the entire process from diagnosis to cure. Again, we work with a network of pharmacists who have been trained to refer anyone whom they suspect may have TB for testing. And of course, we have strong links with the public health system in many different ways.

Let us be realistic – no one group of people can eliminate a disease like tuberculosis. We cannot keep thinking that TB is someone else’s problem. It genuinely requires concerted and sustained efforts from all of us.

5. Where does the common man (the real target) stand in terms of TB awareness and in involvement in TB prevention and control efforts?

When I first began working with REACH, I honestly did not comprehend the scale of the problem. And I think that is what most people think – yes, there is TB but it’s nothing to worry about, although this has somewhat changed with the increased reporting on multi-drug resistant TB over the last year. And of course, there are many who still think TB is a disease of the past.

There is also the idea that TB can only affect certain sections of the population – for example, the perception that only poorer people, those who live in crowded areas can get TB. But TB can affect anyone, irrespective of age, class, gender etc.

Since the national TB programme adopted the DOTS strategy, there have been efforts to involve volunteers as DOT providers, and I think this has had mixed results – very successful in some ways and challenging in others. At REACH, we have been lucky to have several volunteers who have continued to act as DOT providers for TB patients for several years. Many of them began as a provider for a friend or family member and then continued to support others.

Overall, it is true that TB occupies very little space in the public domain. Earlier this year, we ran a campaign for World TB Day where we invited people to organise a small event in their neighbourhood to improve awareness of TB. The idea was simple – it doesn’t take very much to do your bit. We had over 50 people organising small events – a community meeting over tea or a short film screening, for example. We hope that this will in turn create a ripple effect.

6. Your ideas on making media reporting more effective on the issues concerning TB.

We realise that journalists need some support, particularly in terms of resources on TB, access to data and scientists. We look to facilitate these connections – for example, the National Fellow is mentored by a senior scientist through the Fellowship period. Our Local Language Fellows attend an intensive training programme where they interact with several senior scientists and public health specialists. They receive customised toolkits and resources relevant to the issues they are focusing on. We also develop resources on TB specifically for journalists, to demystify scientific jargon, for instance or clearly lay out the basic facts in the form of a primer or FAQ.

What we have realised is that once a journalist starts reporting on TB, s/he continues to follow the issue even after the Fellowship period. What is important is to get TB on the radar, so to speak. After all, we do not want journalists to write one story a day, but more to be aware of the magnitude of the problem and to proactively investigate any leads that may come their way.

7. In your view how has media impacted our efforts towards TB prevention and control?

In the last 24 months, the reporting on TB, at least among the English language media, has exponentially increased. For instance, in 2012, practically every newspaper reported extensively on the cases of drug-resistant TB in Mumbai, that generate considerably debate/ Last year, the media wrote about the ‘drug stock-out’ issue and this had some positive consequences at the local level. Again, our National Media Fellow in 2013 focused on childhood tuberculosis in a series of 22 stories, something previously unprecedented in terms of the depth and breadth of analysis.

By reporting on TB, what can the media achieve? I think they can impact TB prevention and control efforts in the country in many different ways – first of all, broadly, they can improve the quality of the information about TB that is accessible to their readers. By doing so, they can dispel myths and misconceptions. Secondly, through their stories, they can help connect communities to local service providers, and they can promote health-seeking behaviour. Finally, they can hold both the public health system and the private sector accountable and demand action, particularly in times of crises

8. What’s your opinion about the OSDD(Open source drug discovery) model of drug development efforts by the government?

TB has not been a priority for the pharmaceutical industry in the last fifty years, and as a result, there have been next to no new drugs available to fight the disease. In this context, the work of OSDD becomes even more significant. I firmly believe that there is no point in improving awareness on any health issue if we cannot connect people to affordable and accessible treatment, and the availability of cost-effective drugs is a major factor in this. I remain hopeful that the efforts of CSIR will, in the long-run, help alleviate the burden and suffering of those diagnosed with TB in India.

BREAKING BARRIERS

BREAKING BARRIERS.
SONA CHARLES TCOF 4
Women have always contributed despite their socio economic limitations to the cause of the society, Still many a times most of the vast talent goes unutilized. Tata fellowship for women at OSDD is a step in the right direction to utilize the talent of women that gets mired in familial obligations. This way OSDD is a trendsetter just not in open source drug discovery. Here is a sample of the multitude talent that contributes towards OSDD‘s journey.
Talent, ambition, success and a state rank in Kerala during post graduation. Next goal naturally was PhD and Sona was all set to embark on this enthralling journey. She joined Rajiv Gandhi Centre for Biotechnology as PhD student in 2013. Life could not be better for her. All this came to a rude jolt. To quote her,” Unfortunately I had to resign from the position of PhD student since I was pregnant and could not carry out research under a stressful environment. Initially I was broken down as I thought that a woman in family way was not fit for research as many scientists say. I had a career break of 3 months. I utilized these three months in preparing for several competitive exams. The break was never an end to my determination.” And this determination made her apply for TCOF.
After her resignation, Sona appeared for many interviews but her pregnancy made people doubt her continued contribution so she could succeed nowhere. She had heard about OSDD through one of her seniors and was actively following OSDD through Facebook. This is when she got to know about the Tata Fellowships. With the caring support of her PI Dr.Shastry, the facility of online interview and work from home opportunity Sona succeeded in getting the fellowship approved. It is only befitting to note that unconventional thinking has been OSDD’s mantra and we are marching ahead despite difficulties. Where the society doubted Sona’s ability to contribute OSDD took the initiative to grant her a fellowship. After all OSDD is a very woman friendly community where women can work from home. This fellowship has given her hands on experience in the field of drug design. She is a computational person. In her words, she defines her work to the common man thus ‘In ordinary words I am making use of computational methods to filter out some of the best chemical compounds which can be used as drugs against TB after experimental validation. “Sona has made use of the available opportunity to further her cause and to further OSDD’S cause. She judiciously juggles between personal and professional obligations and all this would not have been possible without the facility of online research.
OSDD is a vibrant and pubic platform where each and every individual can contribute based on their profile. OSDD with its open mind welcomes everyone to join hands in combatting neglected diseases.
To quote Sona again “The most important thing I learned through OSDD was that research is not something which we should hide and do. It is important to share your knowledge and work as a team. Everyone may not be experts in all areas. If we are doing research, it should be for a cause. OSDD works for a cause and its vision is worth working for.”
This is just a sample of many such success stories and we will read about others as well. Here’s wishing Sona success as he helps OSDD succeed in its cause for finding a drug for Tuberculosis.

By Chitra Thaneerkulam
Tata Research Fellow

TALKING POINT

Research to Reality
Have you ever wondered how the pill that you pop up or the treatment that you undergo to cure your sickness has evolved? It’s a gripping and amazing story of labor and love that translates research into reality for human betterment. TB research is one such story were scientists and other stakeholders power their passion towards a solution for the many issues around TB. This section of our blog gives a sneak peek into the minds of TB researchers.
Here is a conversation with Dr.S.Jawahar who has been consulting with OSDD in clinical trials.
Too often academicians have their own way of expression far removed from the everyday world of commoners. I had prepared myself towards a conversation that would challenge my comprehending abilities. I was pleasantly surprised when I chanced to talk to Dr.Jawahar who was affable and practical in explaining the issues around TB.
Dr.Jawahar brought to light the crux of the matter in terms of our combat against TB. “Stigma and Misconceptions” these are the two major hurdles in our fight against TB. According to Dr.Jawahar India has a very good reputation when it comes to TB research and drug discovery has gained new impetus with OSDD’s initiative.
So what are the misconceptions and stigma surrounding TB and how can they be corrected?
“Perception in the minds of the people that TB is condemnable leads to people often hesitating to report their condition and seek treatment. Many marriages and families have been shattered by such misconceptions. TB is treatable, curable in most cases. IT IS CRUCIAL TO HAVE AN EARLY DETECTION AND FOLLOW THE FULL COURSE OF TREATMENT”
Surprisingly men seem to be more vulnerable than women though women are at more disadvantage due to socio economic barriers. This brings us to our conversation on gender issues surrounding TB. This is an area of interest to Dr.Jawahar. He lamented that women fear rebuke and reprimand from the society and they often delay or ignore treatment of their health issues and TB is no exception. Its time women realize that their health impacts the well-being of the entire family and come forward to seek treatment.
Getting TB is not mistake, but if you fail to seek treatment, it is a big mistake. This stigma that TB is a crime and incurable has to go and people must realize that there is a solution.
Another misconception pointed out by him is that the TB treatment through the DOTS program of the government may not be as effective as getting treated in private hospitals. DOTS is very effective, safe and the best treatment that one can get for treating TB. It is absolutely FREE.
OK Dr. How are drugs that are developed checked if they are effective and suitable for humans?
Clinical trials. Drugs that have been developed over a period of years and those that have been seen to been effective against the disease are subject to clinical trials involving humans.
Did we not read some time ago that some clinical trials for treating cervical cancer in women resulted in many deaths in Andhra and elsewhere? So why would anyone volunteer for clinical trials?
Clinical trials are Dr.Jawahar’s area of special interest. He assured that clinical trials are safe and ethical. Yes there were some recent disturbing reports on clinical trials that did not follow the right protocol.
“You cannot jump into a clinical trial. Every drug that undergoes a clinical trial has four phases. Before starting the trials an elaborate protocol is evolved and this is reviewed by a scientific committee and after its approval an ethics committee consisting of people from various walks of life including lawyers, interest groups, and common men among others reviews it. After their approval, the participants in the trial are explained about the trial in a manner and language understandable to the participants and are counseled, then they sign their informed voluntary consent before participating. After this, at every stage they are overseen by experts and counseled. So clinical trials are safe and they help the cause of bring out new drugs.”
Dr.Jawahar has been involved in helping OSDD develop the protocol for clinical trials and to guide through its various approvals. Despite clinical trials, TB drugs cause serious side effects like deafness etc. Then why should we take them?
Serious side effects are rare maybe usual side effects are manageable. One usual side effect is the color of the urine that changes to red. Many patients are alarmed. So they are counseled before treatment about this and are urged to continue to finish the full course of treatment.
Why is the treatment for TB very long? Usually within weeks of treatment patients feel fine and why should they still take the drugs?
Currently though TB is curable the duration of the drug intake is long. Especially in the case of Multi drug resistant (MDR TB) TB. Too many drugs and for too long tend to dissuade the patients .But remember it is important to finish the full course. Bad management of the treatment has in fact resulted in new and complicated strains of TB complicating the issue. MDRTB AND XDRTB are pointers to this effect. Remember ANTIIBIOTICS ARE POWERFUL AND EFFECTIVE, BUT IMPROPER USE AND INCOMPLETE COURSE CAN CAUSE HARM.

So what’s the message that we take from our conversation with Dr.Jawahar?
TB is curable and treatable. But seek diagnosis and treatment and finish the full course of treatment though challenging. DOTS the government’s program is very effective.
Currently research is focused on shortening the course of treatment for TB, reducing the number of drugs to be taken. The drug discovery process is long and testing. Nevertheless, brilliant brains are at work in combating TB.
Looking forward to the day when India lands a smart solution for TB.

CAN WE AFFORD THIS?

Affordable Healthcare for All!
Chitra Thaneerkulam
Innovations take us closer to affordable healthcare for all. New cost effective drugs with better efficacy will advance affordability. There is also an invisible facet to affordability. Sure, we have new drugs and diagnostics but we are also compounded with issues like antimicrobial resistance, inaccurate diagnostic procedures, inefficient or wrong treatment protocols and more importantly lack of effective monitoring of disease data!! Affordability becomes a reality only when the veil of these negative factors is torn.
A publication on Dec 11, 2014, of Antimicrobial Resistance: Tackling a Crisis for the Health and Wealth of Nations, from the Review of Antimicrobial Resistance, led by economist Jim O’Neill and informed by two reports prepared by consultants KPMG and RAND Europe estimates that 300 million people will die as a result of drug resistance during the next 35 years. In addition to antibiotic resistance, the review projects figures for resistance to antimalarial, HIV, and tuberculosis drugs. Can we afford this?
Isn’t it time we work to better inform the stakeholders in infection control?
However, the consultants KPMG and RAND also admit the data are unreliable, and state that: “These were considered as proxies in the absence of better data or forecasting tools; much more details and robust work will no doubt be done by academic researchers and clinicians in the future”. The authors also state that their: “teams experienced significant problems with data collection because of the lack of consistent sources monitoring the number of bacterial infections globally”. Can we afford this?
Too often science and social research has been perceived to be dichotomous and isn’t it time we also focus more on socials research of disease along with scientific research to be more effective and affordable? This would take us closer to affordable healthcare for all!!

PLACARDS FOR THE PUBLIC

SPIT AND SPAT NOT FOR US
How often have been witness to spitting in public? How many of us have dared to condemn it? If we dare to do it, we welcome a spiteful much worse a public spat. Isn’t it time we begin our Swachh Bharath Swasth Bharath Mission with a ban on spitting in public places?
————————————————————————————————
Published in the Wall Street Journal in September 2012, this story is still relevant today:
A Woman’s Drug-Resistant TB Echoes Around the Word
http://online.wsj.com/article_email/SB10000872396390444273704577633431646496346-lMyQjAxMTAyMDAwODAwODg3Wj.html?mod=wsj_valetleft_email

—————————————————————————————————-
TB
Know thy symptoms:
• Cough for three weeks or more, sometimes with blood-streaked sputum
• Fever, especially at night
• Weight loss
• Loss of appetite
—————————————————————————————————

DOUBTS ABOUT DOTS

Doubts about Dots
Directly Observed Treatment Short Course (DOTS).
DOTS administered by the Public Health system in the Indian scenario has proved successful with every 8 patient out of 10 treated with DOTS being cured of TB. With a success rate of up to 95% it improves the quality of care. It helps remove poverty, stigma and reduces the burden of the illness. By taking care of patient adherence to treatment and uninterrupted supply of anti -TB drugs, it ensures that TB control efforts are successful.
Despite this, a social assessment study submitted to the Central TB Division, Ministry of Health and Family welfare, Government of India, found that even among poor, marginalized groups, Government health services were sought as a last resort. The most common reason being lack of trust in the system. How do we address this?